TY - JOUR
T1 - Mechanism of inactivation of 3-oxosteroid Δ5-isomerase by 17βo-oxiranes
AU - Bantia, Shanta
AU - Bevins, Charles L
AU - Pollack, Ralph M.
PY - 1985
Y1 - 1985
N2 - The affinity label (17S)-spiro[estra-1,3,5(10),6,8-pentaene-17,2′-oxiran]-3-ol (5β) inactivates 3-oxosteroid Δ5-isomerase from Pseudomonas testosteroni by formation of a covalent bond between Asp-38 of the enzyme and the steroid. High-performance liquid chromatography (HPLC) analysis of tryptic digests of inactivated enzyme shows that two isomeric steroid-containing peptides are formed in a ratio of 9:1 at pH 7 (TPS1 and TPS2). Hydrolysis of each of these peptides produces a different steroid: TPS1 releases 17α-(hydroxymethyl)estra-1,3,5(10),6,8-pentaene-3,17β-diol (S1) whereas TPS2 yields 170-(hydroxymethyl)estra-1,3,5(10),6,8-pentaene-3,17α-diol (S2). Inactivation of the enzyme by (17S)-spiro[estra-1,3,5(10),6,8-pentaene-17,2′-oxiran- 18O]-3-ol, followed by mass spectral analysis of the diacetate of the steroid released upon hydrolysis of the enzyme-inhibitor bond, reveals that TPS1 is formed by attack of Asp-38 at the methylene carbon of the oxirane. In contrast, TPS2 is produced by Asp-38 attack at the tertiary carbon. These results imply that inactivation occurs through concurrent SN1 and SN2 reactions of Asp-38 with the protonated inhibitor and that Asp-38 is located on the a face of the steroid when it is bound to the active site in the correct manner to react for both the SN1 and SN2 processes.
AB - The affinity label (17S)-spiro[estra-1,3,5(10),6,8-pentaene-17,2′-oxiran]-3-ol (5β) inactivates 3-oxosteroid Δ5-isomerase from Pseudomonas testosteroni by formation of a covalent bond between Asp-38 of the enzyme and the steroid. High-performance liquid chromatography (HPLC) analysis of tryptic digests of inactivated enzyme shows that two isomeric steroid-containing peptides are formed in a ratio of 9:1 at pH 7 (TPS1 and TPS2). Hydrolysis of each of these peptides produces a different steroid: TPS1 releases 17α-(hydroxymethyl)estra-1,3,5(10),6,8-pentaene-3,17β-diol (S1) whereas TPS2 yields 170-(hydroxymethyl)estra-1,3,5(10),6,8-pentaene-3,17α-diol (S2). Inactivation of the enzyme by (17S)-spiro[estra-1,3,5(10),6,8-pentaene-17,2′-oxiran- 18O]-3-ol, followed by mass spectral analysis of the diacetate of the steroid released upon hydrolysis of the enzyme-inhibitor bond, reveals that TPS1 is formed by attack of Asp-38 at the methylene carbon of the oxirane. In contrast, TPS2 is produced by Asp-38 attack at the tertiary carbon. These results imply that inactivation occurs through concurrent SN1 and SN2 reactions of Asp-38 with the protonated inhibitor and that Asp-38 is located on the a face of the steroid when it is bound to the active site in the correct manner to react for both the SN1 and SN2 processes.
UR - http://www.scopus.com/inward/record.url?scp=0022429986&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022429986&partnerID=8YFLogxK
M3 - Article
C2 - 4027215
AN - SCOPUS:0022429986
VL - 24
SP - 2606
EP - 2609
JO - Biochemistry
JF - Biochemistry
SN - 0006-2960
IS - 11
ER -